Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Japanese infants and young children with partial-onset seizures
jRCT2080223815Phase 3Completed
- Sponsor
- UCB
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levetiracetam in Focal Onset Epilepsy (2 arms), sponsored by UCB. Primary endpoint: Percent reduction in partial seizure frequency per week from Baseline to Visit 6. Started Feb 2018; status: completed.
02
Drugs
levetiracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on jRCT2080223815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223815.